Saturday, Sep 26, 2020 | Last Update : 08:01 PM IST

186th Day Of Lockdown

Maharashtra130045899280634761 Andhra Pradesh6614585881695606 Tamil Nadu5693705138369148 Karnataka5572124503028417 Uttar Pradesh3785333136865450 Delhi2644502284365147 West Bengal2410592110204665 Odisha201059165432820 Telangana1838661524411091 Bihar175898161510881 Assam167374136712625 Kerala160935111327636 Gujarat1303911105923394 Rajasthan1247301042881412 Haryana1205781012731273 Madhya Pradesh117588932382152 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880
  India   All India  09 Apr 2018  Renewed ayurveda push planned to fight diabetes

Renewed ayurveda push planned to fight diabetes

THE ASIAN AGE. | RAHUL CHHABRA
Published : Apr 9, 2018, 1:01 am IST
Updated : Apr 9, 2018, 1:02 am IST

The CSIR’s role in promoting herbal drugs to treat chronic diseases like diabetes also came up for praise during discussions.

The CSIR, through its laboratories CSIR-Central Institute of Medicinal & Aromatic Plants and CSIR-National Botanical Research Institute, has developed a formulation BGR34 for patients of newly-diagnosed diabetes, said an official. (Photo: Pixabay/Representational)
 The CSIR, through its laboratories CSIR-Central Institute of Medicinal & Aromatic Plants and CSIR-National Botanical Research Institute, has developed a formulation BGR34 for patients of newly-diagnosed diabetes, said an official. (Photo: Pixabay/Representational)

New Delhi: The Union government is planning a renewed push to energise research and development organisation — Council of Scientific and Industrial Research (CSIR) — to systematically and scientifically develop herbal drugs to treat chronic diseases like diabetes in keeping with the WHO Traditional Medicine Strategy 2014-23 that emphasises on integrating traditional and complementary medicine to promote universal healthcare.

With an eye on universal health coverage, which was the focus of the Modi government’s last full-fledged Budget ahead of the 2019 general elections, the Ayush ministry is preparing for a slew of steps to promote alternative traditional medicines, including ayurveda, said an official.

 

The CSIR, through its laboratories CSIR-Central Institute of Medicinal & Aromatic Plants and CSIR-National Botanical Research Institute, has developed a formulation BGR34 for patients of newly-diagnosed diabetes, said an official.

NBRI senior scientist A.K.S Rawat said BGR-34 is made from the extracts of six plants mentioned in Ayurveda after an extensive research by NBRI and Central Institute of Medicinal and Aromatic Plants (CIMAP) scientists.

The anti-diabetic herbal composition BGR-34 for type-2 diabetes mellitus has been developed under the category of “ayurvedic proprietary medicine” as per the Drugs and Cosmetics Act, 1940, rules and has been tested for efficacy and safety in animal models. It is being marketed by AIMIL pharmaceuticals, said Mr Rawat.

 

The growing realisation within the official set up is that traditional medicines are cost effective, easily available and have better physiological compatibility to provide the basic healthcare to all.

During deliberations as part of the World Health Day 2018 observed on April 7 which had the theme — Universal Health Coverage: Everyone, Everywhere — experts asserted that India has a unique opportunity to demonstrate the role of Ayush systems in transforming the current health scenario first in India and then globally.

The CSIR’s role in promoting herbal drugs to treat chronic diseases like diabetes also came up for praise during discussions.

 

Amid fears of the country becoming a diabetic capital of the world, the CSIR and Ayush ministry are planning to launch a campaign to encourage diabetic patients to use ayurvedic drugs, officials said.

Tags: union government, who, modi government, council of scientific and industrial research (csir)